Genetic testing for planning thyroid surgery
Part of Cancer, Hormones & metabolism clinical trials.
This study looks at whether a genetic test called GuidePx® helps doctors plan surgery for thyroid cancer. It may help avoid unnecessary surgeries by guiding the best treatment for each person.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You can communicate in English.
- You have had a thyroid biopsy (FNA) showing either suspicious or cancerous cells (Bethesda V or VI), or cells with certain genetic changes.
- Your thyroid nodule is between 1 and 4 centimeters (about the size of a grape to a walnut).
- Ultrasound shows no spread to neck lymph nodes and no growth outside the thyroid gland.
- You have not had prior thyroid surgery, no history of thyroid cancer, no distant spread, and no past radiation to the head or neck.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares genetic testing results from a small needle biopsy to those from the surgically removed thyroid tissue. It aims to see if the biopsy alone can accurately predict the cancer's genetics, which could help guide treatment decisions.
This trial studies the genetic “mutations” in papillary thyroid cancer tumors using tumor tissue. The goal is to better describe tumor genetic patterns, which may help researchers understand the disease.
This study uses ultrasound images and a quick genetic test to predict if thyroid cancer has spread to lymph nodes in the neck. It aims to help doctors plan surgery more accurately.
This trial tests whether it is safe to avoid immediate surgery and instead monitor small thyroid cancers that are considered low-risk. If you join, doctors will check regularly to make sure the cancer does not grow or spread.
This study looks at how doctors and patients can decide together on the best way to treat low-risk thyroid cancer. It aims to help you choose a treatment that fits your values and needs, while keeping your cancer under control.
This trial tests whether giving targeted drugs before surgery can help shrink advanced thyroid cancers, making them easier to remove. It uses your tumor's genetic profile to choose the best treatment for you.
Hear when a new Papillary Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.